Eloxx Pharmaceuticals (ELOX) Non-Current Assets (2011 - 2023)
Eloxx Pharmaceuticals (ELOX) reported Non-Current Assets of $164,000 for Q4 2023, down 83.5% from $994,000 a year earlier and down 60.3% from the prior quarter.
Powered by 
Analysis
Eloxx Pharmaceuticals (ELOX) Non-Current Assets (2011 - 2023) Analysis & Trends
Dating back to Q4 2015, Eloxx Pharmaceuticals' Non-Current Assets record includes 29 quarters.
- Non-Current Assets has a five-year compound annual growth rate of -15.3% (FY2018 to FY2023).
- By year, Non-Current Assets came in at $994,000 in FY2022 (-40.1%), $1.66 million in FY2021 (+184.1%), $584,000 in FY2020 (-52.8%) and $1.24 million in FY2019 (+228.4%).
- The Q4 2023 figure ranks as the lowest quarterly Non-Current Assets since Q4 2016.
- Year over year, Non-Current Assets has now declined in each of the last seven quarters, with an average decline of 12.0% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q1 2019 (growth of 355.7%); the low point was Q4 2023 (a decline of 83.5%).
- Per Business Quant data, the three quarters before Q4 2023 came in at $413,000 (Q3 2023), $611,000 (Q2 2023) and $797,000 (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,172.56 Bn | 1,141.15 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 637.42 Bn | 555.95 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 504.13 Bn | 477.24 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 377.81 Bn | 332.19 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 304.36 Bn | 268.35 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 267.51 Bn | 241.20 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 242.18 Bn | 197.58 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 194.29 Bn | 168.48 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 172.82 Bn | 119.47 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Eloxx Pharmaceuticals | 88.39 Mn | 14.71 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 164,000.00 |
| Sep 30, 2023 | 413,000.00 |
| Jun 30, 2023 | 611,000.00 |
| Mar 31, 2023 | 797,000.00 |
| Dec 31, 2022 | 994,000.00 |
| Sep 30, 2022 | 1.21 Mn |
| Jun 30, 2022 | 1.35 Mn |
| Mar 31, 2022 | 1.47 Mn |
| Dec 31, 2021 | 1.66 Mn |
| Sep 30, 2021 | 1.84 Mn |
| Jun 30, 2021 | 2.05 Mn |
| Mar 31, 2021 | 406,000.00 |
| Dec 31, 2020 | 584,000.00 |
| Sep 30, 2020 | 730,000.00 |
| Jun 30, 2020 | 953,000.00 |
| Mar 31, 2020 | 1.11 Mn |
| Dec 31, 2019 | 1.24 Mn |
| Sep 30, 2019 | 1.20 Mn |
| Jun 30, 2019 | 1.30 Mn |
| Mar 31, 2019 | 1.43 Mn |
API Access
Eloxx Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ELOX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ELOX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ELOX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();